A Johnson & Johnson executive with a dealmaking background is leaving the pharmaceutical giant to join
Peter Kerrane is joining the firm as a managing director in its health-care investment banking group covering large pharmaceutical companies, according to a memo from the Zurich-based lender reviewed by Bloomberg.
“This hire demonstrates the critical importance of our life sciences franchise and will help us continue to build on the momentum we have generated within health care over the last year,”
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.